 |
|
| Blog results | Results 1 - 10 of about 26,962 for high dose atorvastatin. (0.36 seconds) |
| Sorted by relevance Sort by date |
| 8 Nov 2009 It is currently unknown what would be the best treatment option for patients with mixed hyperlipidemia who fail to meet their lipid targets with statin monotherapy at conventional does, i.e. high dose rosuvastatin or conventional statin ... Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r... [ More results from Clinical Trials Updates During the Last 7 Days ] |
| 22 Nov 2009 by DoctorFrog Then the truly seminal Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial showed that high-dose atorvastatin reduced the risk of subsequent stroke in patients without known coronary artery disease who had a ... Procto-Med - http://www.procto-med.com/ |
| 1 hour ago by Sotirios Tsimikas Novel Approaches for Preventing or Limiting Events (Naples) II Trial: Impact of a Single High Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction , 10 August 2009. Carlo Briguori, Gabriella Visconti, Amelia Focaccio, ... Journal of the American College of Cardiology - http://www.journals.elsevierhealth.com/periodical... [ More results from Journal of the American College of Cardiology ] |
| 13 Oct 2009 by Admin High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial. Circulation. 2004 Sep 14;110(11):1406-12. ... The Cholesterol Conspiracy Podcast - http://www.cholesterolconspiracy.com/ [ More results from The Cholesterol Conspiracy Podcast ] |
| 18 Apr 2007 by Oktem, M., Esinler, I., Eroglu, D., Haberal,... Group I (Low-dose atorvastatin group, eight rats) were given 0.5 mg kg–1 day–1 oral atorvastatin. Group II (High-dose atorvastatin group, 10 rats) were given 2.5 mg kg–1 day–1 oral atorvastatin. Group III were given a single dose of 1 ... Human Reproduction - Advance Access - http://humrep.oxfordjournals.org/ |
| 20 Jun 2007 by Lindgren, P., Graff, J., Olsson, AG, Pedersen,... Aims: The aim of the study was to evaluate the long-term cost-effectiveness of high-dose atorvastatin when compared with generic simvastatin for secondary prevention in Denmark, Finland, Norway, and Sweden based on the recently ... European Heart Journal - recent issues - http://eurheartj.oxfordjournals.org/ |
| 11 Oct 2006 (NaturalNews) According to new research published in the October issue of the Journal of the American Dietetic Association, patients with high cholesterol who are taking high-dose statin drugs may be able to reduce the effects on their ... NewsTarget.com - http://www.newstarget.com/ |
| 15 Nov 2005 In a randomized study, intensive lowering of LDL-C did not significantly reduce major coronary events, but did reduce other composite secondary end points and nonfatal acute MI risks. Medscape Diabetes Headlines - http://www.medscape.com/diabetes-endocrinologyhome - References |
| 29 Jul 2009 IDEAL included 8888 patients with a history of AMI who were randomly assigned to intensive therapy with high-dose atorvastatin 80 mg/day or simvastatin 20 mg/day that could be titrated up to 40 mg/day. Results showed that a composite ... Lipids Online News - http://www.lipidsonline.org/ [ More results from Lipids Online News ] |
| 29 Apr 2009 Among the 20 patients who completed the study, there was a significant reduction from baseline in signal intensity, the USPIO-enhanced MRI definition of plaque inflammation, in the high-dose atorvastatin arm at six and 12 weeks. ... theHeart.org - http://www.theheart.org/ - References [ More results from theHeart.org ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
